+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadopentetate Dimeglumine Market - Global Forecast 2025-2030- Product Image
Gadopentetate Dimeglumine Market - Global Forecast 2025-2030- Product Image
Sale

Gadopentetate Dimeglumine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6129142
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior healthcare decision-makers navigating the contrast agent landscape rely on precise, actionable intelligence. The Gadopentetate Dimeglumine market is undergoing transformative changes shaped by advances in diagnostic technology, evolving clinical protocols, and dynamic global supply chain pressures.

Market Snapshot: Gadopentetate Dimeglumine Outlook

The Gadopentetate Dimeglumine market remains integral to diagnostic imaging, supporting a range of high-value medical specialties. Current trends include the integration of advanced imaging protocols, personalized medicine approaches, and a focus on regulatory compliance and value-based procurement. As imaging demands continue to grow, stakeholders are balancing the need for high-resolution diagnostics with safety and cost transparency.

Scope & Segmentation: Comprehensive Market Structure

This report provides a structured analysis across all key dimensions of the Gadopentetate Dimeglumine sector. Stakeholders can benchmark opportunities based on the following market segmentation:

  • Application Areas: Cardiovascular System (Morphological Imaging, Perfusion Imaging), Central Nervous System (Brain Imaging, Spinal Cord Imaging), Musculoskeletal System (Bone Imaging, Joint Imaging, Soft Tissue Imaging), Oncology (Metastasis Imaging, Tumor Characterization, Tumor Detection)
  • End Users: Academic and Research Institutes, Ambulatory Care Facilities (Outpatient Clinics), Diagnostic Centers (Multi-Specialty Diagnostics, Standalone Imaging Centers), Hospitals (Private and Public Hospitals)
  • Form Factors: Pre Filled Syringes, Vials (Multi Dose Vials, Single Dose Vials)
  • Distribution Channels: Direct Sales, Distributor Sales, Online Sales
  • Geographies: Americas (including United States states such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Bayer AG, Bracco Imaging S.p.A., GE HealthCare Technologies, Inc., Guerbet S.A., Mallinckrodt plc, Lantheus Holdings, Inc., Sagent Pharmaceuticals, Inc., Dr. Reddy's Laboratories Limited, Accord Healthcare Limited, Shanghai Bracco Sine Pharmaceutical Corp., Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • The primary keyword, Gadopentetate Dimeglumine, continues to drive advancements in diagnostic imaging through its proven contrast efficacy in vascular and soft tissue visualization.
  • Emerging technologies such as artificial intelligence are enhancing the accuracy of radiological interpretation, fostering collaborations between contrast developers and technology partners.
  • Personalized imaging protocols are on the rise, with tailored contrast solutions increasingly aligned to individual patient profiles and risk factors.
  • Sustainability initiatives are prompting manufacturers to develop eco-conscious formulations and packaging, in response to both regulatory and institutional mandates.
  • Regional adoption dynamics vary; mature markets invest in protocol innovation, while developing regions focus on capacity building and enhanced access to reliable contrast agents.
  • Industry partnerships are pivoting toward integrated diagnostic solutions, blending clinical analytics with advanced agent delivery for improved therapeutic outcomes.

Tariff Impact: Navigating 2025 Supply Chain Changes

Tariffs imposed in the United States in 2025 have escalated supply chain costs for Gadopentetate Dimeglumine, compelling companies to revisit procurement strategies and optimize inventory. Manufacturers are reinforcing relationships with logistics providers and regional distributors, mitigating the impact through alternative sourcing and distribution hubs. These actions help address cost volatility and safeguard contract stability for healthcare customers managing pricing pressures.

Methodology & Data Sources

Insights are grounded in a rigorous multi-tiered research model. Primary data was collected from interviews with radiologists, procurement specialists, and R&D executives. Extensive secondary research included regulatory reviews and analysis of peer-reviewed publications. Data triangulation and expert panel validation ensured accuracy and reliability throughout the market assessment.

Why This Report Matters

  • Delivers a holistic perspective to inform strategic investments, keeping stakeholders competitive in a fast-moving imaging market.
  • Enables senior executives to anticipate supply chain disruptions and regulatory changes, supporting adaptive procurement decisions.
  • Equips cross-functional teams with practical recommendations to capture emerging opportunities in technology, segments, and global regions.

Conclusion

Gadopentetate Dimeglumine sits at the intersection of clinical innovation and operational agility. Decision-makers equipped with these insights can proactively respond to evolving trends and unlock strategic advantages in the diagnostic imaging sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing preference for macrocyclic gadolinium-based contrast agents over linear formulations due to lower retention rates
5.2. Increasing adoption of high-field MRI scanners driving demand for optimized gadopentetate dimeglumine protocols in advanced imaging
5.3. Stringent regulatory framework updates on gadolinium safety prompting manufacturers to reformulate contrast agents to meet new guidelines
5.4. Surge in neurological disorder diagnoses fueling increased utilization of gadopentetate dimeglumine for brain and spine imaging applications
5.5. Market expansion in Asia-Pacific led by rising healthcare infrastructure investments and favorable reimbursement policies for MRI procedures
5.6. Ongoing clinical research into gadolinium retention effects influencing purchasing decisions among radiology departments worldwide
5.7. Competitive pressure from alternative contrast agents such as iron-based formulations driving price negotiations for gadopentetate dimeglumine
5.8. Strategic partnerships between contrast agent manufacturers and imaging centers enhancing supply chain resilience and distribution efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gadopentetate Dimeglumine Market, by Application
8.1. Introduction
8.2. Cardiovascular System
8.2.1. Morphological Imaging
8.2.2. Perfusion Imaging
8.3. Central Nervous System
8.3.1. Brain Imaging
8.3.2. Spinal Cord Imaging
8.4. Musculoskeletal System
8.4.1. Bone Imaging
8.4.2. Joint Imaging
8.4.3. Soft Tissue Imaging
8.5. Oncology
8.5.1. Metastasis Imaging
8.5.2. Tumor Characterization
8.5.3. Tumor Detection
9. Gadopentetate Dimeglumine Market, by End User
9.1. Introduction
9.2. Academic And Research Institutes
9.3. Ambulatory Care Facilities
9.3.1. Outpatient Clinics
9.4. Diagnostic Centers
9.4.1. Multi Specialty Diagnostics
9.4.2. Standalone Imaging Centers
9.5. Hospitals
9.5.1. Private Hospitals
9.5.2. Public Hospitals
10. Gadopentetate Dimeglumine Market, by Form
10.1. Introduction
10.2. Pre Filled Syringes
10.3. Vials
10.3.1. Multi Dose Vials
10.3.2. Single Dose Vials
11. Gadopentetate Dimeglumine Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
11.4. Online Sales
12. Americas Gadopentetate Dimeglumine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gadopentetate Dimeglumine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gadopentetate Dimeglumine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. Bracco Imaging S.p.A.
15.3.3. GE HealthCare Technologies, Inc.
15.3.4. Guerbet S.A.
15.3.5. Mallinckrodt plc
15.3.6. Lantheus Holdings, Inc.
15.3.7. Sagent Pharmaceuticals, Inc.
15.3.8. Dr. Reddy's Laboratories Limited
15.3.9. Accord Healthcare Limited
15.3.10. Shanghai Bracco Sine Pharmaceutical Corp., Ltd.
16. ResearchAI17. ResearchStatistics18. ResearchContacts19. ResearchArticles20. Appendix
List of Figures
FIGURE 1. GADOPENTETATE DIMEGLUMINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GADOPENTETATE DIMEGLUMINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. GADOPENTETATE DIMEGLUMINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. GADOPENTETATE DIMEGLUMINE MARKET: RESEARCHAI
FIGURE 24. GADOPENTETATE DIMEGLUMINE MARKET: RESEARCHSTATISTICS
FIGURE 25. GADOPENTETATE DIMEGLUMINE MARKET: RESEARCHCONTACTS
FIGURE 26. GADOPENTETATE DIMEGLUMINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GADOPENTETATE DIMEGLUMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MORPHOLOGICAL IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MORPHOLOGICAL IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY BONE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY BONE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY JOINT IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY JOINT IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SOFT TISSUE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SOFT TISSUE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY METASTASIS IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY METASTASIS IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY TUMOR CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY TUMOR CHARACTERIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MULTI SPECIALTY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MULTI SPECIALTY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STANDALONE IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STANDALONE IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MULTI DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SINGLE DOSE VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY SINGLE DOSE VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 145. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 148. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 149. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 150. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 151. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 152. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 153. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 154. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 155. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 158. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 159. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 160. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 161. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 164. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 165. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 166. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 167. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 172. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 173. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 174. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 175. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 176. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 177. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 188. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 189. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. MEXICO GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY VIALS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2018-2024 (USD MILLION)
TABLE 294. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CARDIOVASCULAR SYSTEM, 2025-2030 (USD MILLION)
TABLE 295. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 296. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 297. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2018-2024 (USD MILLION)
TABLE 298. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY MUSCULOSKELETAL SYSTEM, 2025-2030 (USD MILLION)
TABLE 299. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY AMBULATORY CARE FACILITIES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 308. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 309. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 310. GERMANY GADOPENTETATE DIMEGLUMINE MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gadopentetate Dimeglumine Market report include:
  • Bayer AG
  • Bracco Imaging S.p.A.
  • GE HealthCare Technologies, Inc.
  • Guerbet S.A.
  • Mallinckrodt plc
  • Lantheus Holdings, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories Limited
  • Accord Healthcare Limited
  • Shanghai Bracco Sine Pharmaceutical Corp., Ltd.

Related Reports

Gadopentetate Dimeglumine API Market - Global Forecast 2025-2030 - Product Image

Gadopentetate Dimeglumine API Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Gadolinium Contrast Media Market - Global Forecast 2025-2030 - Product Image

Gadolinium Contrast Media Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 168 Pages
  • Global
From
Fosaprepitant Dimeglumine (CAS 265121-04-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Fosaprepitant Dimeglumine (CAS 265121-04-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
MRI Contrast Media Market Report 2025 - Product Image

MRI Contrast Media Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.